At the Crossroads of Inflammation and Tumorigenesis

In this issue of The Journal of Experimental Medicine , Hudson et al. ([1][1]) report on the identification of a cytokine, the macrophage migration inhibitory factor or MIF, that overcomes p53 function by suppressing its transcriptional activity, thus linking complex programs that govern

[1]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[2]  C. Prives,et al.  Covalent and noncovalent modifiers of the p53 protein , 1999, Cellular and Molecular Life Sciences CMLS.

[3]  Barbara Magi,et al.  Protein expression profiles in human breast ductal carcinoma and histologically normal tissue , 1997, Electrophoresis.

[4]  J. Müller,et al.  K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis , 1999, Langenbeck's Archives of Surgery.

[5]  A. Böhmer,et al.  Macrolides and community-acquired pneumonia: is quorum sensing the key? , 2010, Critical care.

[6]  Pack,et al.  Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis. , 1998, International journal of molecular medicine.

[7]  S. Spechler.  The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. , 1999, Gastroenterology.

[8]  G. Hannon,et al.  A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.

[9]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[10]  C. Cordon-Cardo.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. , 1995, The American journal of pathology.

[11]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[12]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[13]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[14]  C. Bassi,et al.  Incidence of cancer in the course of chronic pancreatitis , 1999, American Journal of Gastroenterology.

[15]  E. Zarling,et al.  Chronic inflammation and cancer: potential role of Bcl-2 gene family members as regulators of cellular antioxidant status. , 1999, Medical hypotheses.

[16]  K. Meyer-Siegler,et al.  Expression of Macrophage Migration Inhibitory Factor in the Human Prostate , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[17]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[18]  D. Meek.  Post-translational modification of p53. , 1994, Seminars in cancer biology.

[19]  A. Öst,et al.  Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis , 1999, International Journal of Colorectal Disease.

[20]  W. Gong,et al.  Chemokines and their role in tumor growth and metastasis. , 1998, Journal of immunological methods.

[21]  K. Meyer-Siegler,et al.  Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. , 1996, Urology.